NCT06461884 Combined Effects Of Percussion With Diaphragmatic Breathing Exercises On Airway Clearance In Elderly Pneumonia Patients
| NCT ID | NCT06461884 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Pneumonia |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-03-10 |
| Primary Completion | 2024-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-03-10 with a primary completion date of 2024-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The group A will receive percussions and diaphragmatic breathing with 1 session a day for 3 days in a week for 4 weeks. In this way total 12 sessions will be given to the patients. And group B will receive only diaphragmatic breathing with 1 session a day for total 3 days in a week for 4 weeks. By this intervention procedure, I will find out the effects of these techniques on airway clearance of the pneumonia patients, their effect on the quality of life and on Dyspnea. For this I will use 4 tool questionnaires that are 1-BCSS, 2- Modified Borg Dyspnea scale, 3-Rate of perceived exertion scale, 4- Health-related Quality of Life-14. BCSS will be used to assess breathlessness, cough and sputum retention. Modified Borg Dyspnea scale is 0-10 rated numerical scale used to measure Dyspnea. RPE is a way to measure the level of exertion a person feels during physical activity. HRQOL-14 will assess the quality of life of the pneumonia patients.
Eligibility Criteria
Inclusion Criteria: * Patients aged 40-60, * Both males and females * Those patients who will be vitally stable (oxygen saturation, respiratory rate) * Pneumonia diagnosed patients (Community Acquired Pneumonia) Exclusion Criteria: * Patients with heart disease * Patients with neurological disorders such as: Alzheimer, epilepsy, Parkinson disease * Patients with orthopedic conditions * Other pulmonary complications (atelectasis, diaphragmatic injury, ARDS)
Contact & Investigator
Sidra Faisal, PP-DPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06461884 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06461884 currently recruiting?
Yes, NCT06461884 is actively recruiting participants. Contact the research team at iqbal.tariq@riphah.edu.pk for enrollment information.
Where is the NCT06461884 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06461884 clinical trial?
NCT06461884 is sponsored by Riphah International University. The principal investigator is Sidra Faisal, PP-DPT at Riphah International University. The trial plans to enroll 40 participants.